These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17905235)

  • 21. Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?
    Orvieto R; Rabinson J; Meltcer S; Gemer O; Anteby EY; Zohav E
    Fertil Steril; 2008 Mar; 89(3):736-7. PubMed ID: 17498708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impact of controlled ovarian hyperstimulation delayed, which occurs after functionally pituitary downregulation by depot GnRH agonist, on the outcome of in vitro fertilization and embryo transfer].
    Ma QH; Li SW; Huang ZY; Han ZY; Qiu DS; Han DW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):980-3. PubMed ID: 18095601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IVF: past and future.
    Jones HW
    Reprod Biomed Online; 2003; 6(3):375-81. PubMed ID: 12735878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
    Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The J-Tip Needle-Free Injection System in controlled ovarian hyperstimulation in in vitro fertilization: a pilot study.
    Lavery SA; El-Shawarby SA; Turner C; Trew G
    Fertil Steril; 2008 Nov; 90(5):1969-72. PubMed ID: 18166182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
    Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
    Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
    Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
    West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of in vitro fertilization in the United States: a conversation between Zev Rosenwaks and Jairo E. Garcia.
    Garcia JE; Rosenwaks Z
    Fertil Steril; 2018 Jul; 110(1):14-18. PubMed ID: 29980255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation.
    Almog B; Azem F; Gordon D; Pauzner D; Amit A; Barkan G; Levin I
    Fertil Steril; 2012 Oct; 98(4):957-60. PubMed ID: 22763097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature.
    Pinto E; Pinelo S; Osório M; Ferreira C; Serra H; Pires I; Barbosa A; Figueiredo H; Felgueira E; Tavares A
    Gynecol Endocrinol; 2012 Jul; 28(7):545-8. PubMed ID: 22439899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Middle cerebral artery thrombosis after IVF and ovarian hyperstimulation: a case report.
    Jing Z; Yanping L
    Fertil Steril; 2011 Jun; 95(7):2435.e13-5. PubMed ID: 21601668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IVF: a short but exciting story.
    Garcia Velasco JA; Seli E
    Curr Opin Obstet Gynecol; 2015 Jun; 27(3):165-6. PubMed ID: 25919232
    [No Abstract]   [Full Text] [Related]  

  • 35. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian hyperstimulation: past, present, and future.
    Feinberg EC
    Fertil Steril; 2016 Nov; 106(6):1330. PubMed ID: 27678039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
    Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
    Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A profile of Bruno Lunenfeld, MD, FRCOG, FACOG (hon).
    Romero R
    Am J Obstet Gynecol; 2018 Sep; 219(3):225-234. PubMed ID: 30170793
    [No Abstract]   [Full Text] [Related]  

  • 39. LH supplementation in mild stimulations cycles without pituitary suppression: a retrospective analysis.
    Paragona M; Rossini M; Dattilo M; Stamm J
    Gynecol Endocrinol; 2013 Feb; 29(2):101-4. PubMed ID: 23256611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended induction of ovulation by human menopausal gonadotropins and a gonadotropin-releasing hormone analog in high responders for in vitro fertilization and oocyte donation.
    Amit A; Yaron Y; Azem F; Peyser MR; David MP; Lessing JB
    J Reprod Med; 1995 Sep; 40(9):633-7. PubMed ID: 8576879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.